Document is current
Any future updates will be listed below
-
Authors
Zhao, Ting
Xiao, Xiao
Li, Lingchuan
Wei, Yanmeng
Shi, Huacong
Yang, Guohua
Yuan, Tao
-
Funding
Funding for this research was provided by:
Yunnan Provincial Center for Obstetrics and Gynecology Research (2022YJZX-FC08; 2023YJZX-FC05)
Key Laboratory of Birth Defects and Genetic Diseases Research in Yunnan Province (2022ZDFKT002)
National Natural Science Foundation of China (82460299)
Medical Reserve Talent of Yunnan Provincial Health Commission ((H-2024003)
the Xingdian Talent Support Program for Medical and Health Talents (XDYC-YLWS-2023-0073)
Central Government Guidance Fund for Local Science and Technology Development (202407AB110013)
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 23 October 2025
First Online: 18 November 2025
Declarations
:
: This study was approved by the Experimental Animal Ethics Committee of Kunming University of Science and Technology (Title of the approved project: The mechanism of PRP mediating Kisspeptin in premature ovarian insufficiency by regulating Rictor/mTORC2; Number of acceptances:202401AS070153; Date of approval: August 5, 2024). All experimental procedures will strictly comply with the requirements of the Ethics Committee and the Laboratory Animal Welfare Committee. The work has been reported in line with the ARRIVE guidelines 2.0. The authors declare that they have not use AI-generated work in this manuscript in this section.
: Not applicable.
: The authors declare no competing interests.
